Stefan K.F. Schwabe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stefan K.F. Schwabe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stefan K.F. Schwabe. Stefan K.F. Schwabe is Executive Vice President & CMO in SUPERNUS PHARMACEUTICALS, INC. ($SUPN) and Executive Vice President R&D in SUPERNUS PHARMACEUTICALS INC ($SUPN) and Executive VP R&D, CMO in SUPERNUS PHARMACEUTICALS INC ($SUPN).
Latest Insider Trading Transactions of Stefan K.F. Schwabe
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | M | 12.98 | 46,347 | 601,584 | 0 | |
| Dec 22 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 22.10 | 46,347 | 1,024,463 | 2,772 | 49.1 K to 2.8 K (-94.36 %) |
| Dec 22 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Buy | M | 12.98 | 46,347 | 601,584 | 49,119 | 2.8 K to 49.1 K (+1,671.97 %) |
| Dec 15 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | M | 12.98 | 3,653 | 47,416 | 46,347 | |
| Dec 15 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | M | 9.13 | 50,000 | 456,500 | 0 | |
| Dec 15 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 22.00 | 3,653 | 80,369 | 2,772 | 6.4 K to 2.8 K (-56.86 %) |
| Dec 15 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 21.86 | 50,000 | 1,092,895 | 6,425 | 56.4 K to 6.4 K (-88.61 %) |
| Dec 15 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Buy | M | 12.98 | 3,653 | 47,416 | 56,425 | 52.8 K to 56.4 K (+6.92 %) |
| Dec 15 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Buy | M | 9.13 | 50,000 | 456,500 | 52,772 | 2.8 K to 52.8 K (+1,803.75 %) |
| Feb 26 2019 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 36.75 | 40,000 | 1,470,000 | 40,000 | |
| Jun 19 2018 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive VP R&D, C ... | Option Exercise | M | 9.24 | 40,000 | 369,600 | 0 | |
| Jun 19 2018 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive VP R&D, C ... | Option Exercise | M | 7.90 | 20,000 | 158,000 | 0 | |
| Jun 19 2018 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive VP R&D, C ... | Sell | S | 54.39 | 60,000 | 3,263,352 | 1,967 | 62 K to 2 K (-96.83 %) |
| Jun 19 2018 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive VP R&D, C ... | Buy | M | 9.24 | 40,000 | 369,600 | 61,967 | 22 K to 62 K (+182.09 %) |
| Jun 19 2018 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive VP R&D, C ... | Buy | M | 7.90 | 20,000 | 158,000 | 21,967 | 2 K to 22 K (+1,016.78 %) |
| Feb 16 2018 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 39.40 | 30,000 | 1,182,000 | 30,000 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | M | 12.92 | 95,000 | 1,227,400 | 0 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 46.59 | 95,000 | 4,425,575 | 1,855 | 96.9 K to 1.9 K (-98.08 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Buy | M | 12.92 | 95,000 | 1,227,400 | 96,855 | 1.9 K to 96.9 K (+5,121.29 %) |
| Feb 27 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 25.30 | 50,000 | 1,265,000 | 50,000 | |
| Mar 03 2016 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 12.98 | 50,000 | 649,000 | 50,000 | |
| Jul 29 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 21.20 | 1,700 | 36,040 | 0 | 1.7 K to 0 (-100.00 %) |
| Jul 29 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 21.21 | 650 | 13,787 | 1,700 | 2.4 K to 1.7 K (-27.66 %) |
| Jul 14 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 19.23 | 1,950 | 37,499 | 844 | 2.8 K to 844 (-69.79 %) |
| Jun 15 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 18.27 | 2,051 | 37,472 | 2,794 | 4.8 K to 2.8 K (-42.33 %) |
| Jun 12 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 16.44 | 2,286 | 37,570 | 4,845 | 7.1 K to 4.8 K (-32.06 %) |
| Jun 12 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 16.32 | 1,345 | 21,950 | 7,131 | 8.5 K to 7.1 K (-15.87 %) |
| Mar 05 2015 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 9.13 | 50,000 | 456,500 | 50,000 | |
| Feb 07 2013 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 7.90 | 20,000 | 158,000 | 20,000 | |
| Sep 07 2012 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | A | 12.92 | 95,000 | 1,227,400 | 95,000 |
Page: 1